Earnings Feed
Start Free
Turning Point Therapeutics, Inc.·4

Feb 11, 6:11 PM ET

TOMBESI PAOLO 4

4 · Turning Point Therapeutics, Inc. · Filed Feb 11, 2022

Insider Transaction Report

Form 4
Period: 2022-02-09
Turning Point Therapeutics, Inc.TPTX
TOMBESI PAOLO
EVP & Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-02-09+16,283→ 29,883 total
  • Award

    Stock Option (right to buy)

    2022-02-09+58,600→ 58,600 total
    Exercise: $37.68Exp: 2032-02-08→ Common Stock (58,600 underlying)
Footnotes (2)
  • [F1]Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan.
  • [F2]1/48th of the shares vest monthly following February 9, 2022.

Documents

2 files